ENYO Pharma
Developing therapeutics for diseases with impaired kidney function
35 employees · est. 2014 · Lyon, France
Reistone Biopharma
Focusing on rapidly developing innovative medicines through global collaborations within Research and Development
52 employees · est. 2018 · China
ENYO Pharma is the older company (2014 vs 2018); Reistone Biopharma is the larger of the two.
Side-by-Side Comparison
| Metric | ENYO Pharma | Reistone Biopharma |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2018 |
| Headquarters | ||
| Headquarters | Lyon, France | China |
| Employees | ||
| Employees | 35 | 52 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Series A |
| Total Funding | ||
| Total Funding | $103.50M | $100.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Developing therapeutics for diseases with impaired kidney function | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with impaired kidney function, pharmaceutical companies, research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Therapeutics, Chronic Kidney Diseases, Rare Kidney Diseases, Liver Diseases, Infectious Diseases, Vonafexor, Intracellular Therapeutic Targets, Anti-virals, Drug Development, Phase 2 Trials, Research And Development, Inserm Patents, Viral Treatments, Global Leader | Biopharmaceutical, R&D, Innovative Medicines, Global Collaborations, Clinical Stage, Autoimmune Diseases, Therapies Development, Unmet Medical Needs, Pharmaceutical Industry, Regulatory Collaboration, Patient Groups, Drug Development, China, Global Impact |
| Website | ||
| Website | enyopharma.com | reistonebio.com |
About ENYO Pharma
ENYO Pharma is a biopharmaceutical company that focuses on developing therapeutics for diseases with impaired kidney function. The company's lead compound, Vonafexor, is currently undergoing Phase 2 trials for Chronic Kidney Diseases (CKD), rare kidney diseases such as Alport syndrome, and liver dis...
About Reistone Biopharma
Reistone Biopharma is a clinical stage biopharmaceutical company founded in 2018. The company's slogan "Focusing on rapidly developing innovative medicines through global collaborations within Research and Development" underlines its commitment to developing novel medicines for life-threatening auto...
We will tell you when either one moves
BounceWatch watches ENYO Pharma and Reistone Biopharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ENYO Pharma and Reistone Biopharma — by email.
Frequently Asked Questions
Compare ENYO Pharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ENYO Pharma on 11 Jun 2025, and Reistone Biopharma on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
